Clinical Trials Browser

Interventional × Pancreatic Neoplasms × Radiation Dose Hypofractionation × Clear all

NCT04172532 2026-03-18

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06435260 2025-06-26

Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04106856 2025-04-06

SHAPER

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms